Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma

Mahmoud A L Sheikh Ali, Mehmet Gunduz, Hitoshi Nagatsuka, Esra Gunduz, Beyhan Cengiz, Kunihiro Fukushima, Levent Bekir Beder, Kadir Demircan, Masae Fujii, Noboru Yamanaka, Kenji Shimizu, Reidar Grenman, Noriyuki Nagai

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

The epidermal growth factor receptor (EGFR)-RAS-RAF-mitogen-activated protein kinase signaling cascade is an important pathway in cancer development and recent reports show that EGFR and its downstream signaling molecules are mutated in a number of cancers. We have analyzed 91 Japanese head and neck squamous cell carcinomas (HNSCC) and 12 HNSCC cell lines for mutations in EGFR, ErbB2, and K-ras. Exons encoding the hot-spot regions in the tyrosine kinase domain of both EGFR (exons 18, 19, and 21) and ErbB2 (exons 18-23), as well as exons 1 and 2 of K-ras were amplified by polymerase chain reaction and sequenced directly. EGFR expression was also analyzed in 65 HNSCC patients using immunohistochemistry. Only one silent mutation, C836T, was found in exon 21 of EGFR in the UT-SCC-16A cell line and its corresponding metastasic cell line UT-SCC-16B. No other mutation was found in EGFR, ErbB2, or K-ras. All tumors showed EGFR expression. In 21 (32%) tumors, EGFR was expressed weakly (+1). In 27 (42%) tumors it was expressed (+2) moderately, and in 17 (26%) tumors high expression (+3) was detected. Overexpression (+2, +3) was found in 44 tumors (68%). A worse tumor differentiation and a positive nodal stage were significantly associated with EGFR overexpression (P = 0.02, P = 0.032, respectively). Similar to patients from western ethnicity, mutations are absent or rare in Japanese HNSCC. Protein overexpression rather than mutation might be responsible for activation of the EGFR pathway in HNSCC.

Original languageEnglish
Pages (from-to)1589-1594
Number of pages6
JournalCancer Science
Volume99
Issue number8
DOIs
Publication statusPublished - 2008

Fingerprint

Epidermal Growth Factor Receptor
Mutation
Exons
Neoplasms
Cell Line
Carcinoma, squamous cell of head and neck
Mitogen-Activated Protein Kinases
Protein-Tyrosine Kinases
Immunohistochemistry
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. / Sheikh Ali, Mahmoud A L; Gunduz, Mehmet; Nagatsuka, Hitoshi; Gunduz, Esra; Cengiz, Beyhan; Fukushima, Kunihiro; Beder, Levent Bekir; Demircan, Kadir; Fujii, Masae; Yamanaka, Noboru; Shimizu, Kenji; Grenman, Reidar; Nagai, Noriyuki.

In: Cancer Science, Vol. 99, No. 8, 2008, p. 1589-1594.

Research output: Contribution to journalArticle

Sheikh Ali, MAL, Gunduz, M, Nagatsuka, H, Gunduz, E, Cengiz, B, Fukushima, K, Beder, LB, Demircan, K, Fujii, M, Yamanaka, N, Shimizu, K, Grenman, R & Nagai, N 2008, 'Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma', Cancer Science, vol. 99, no. 8, pp. 1589-1594. https://doi.org/10.1111/j.1349-7006.2008.00861.x
Sheikh Ali, Mahmoud A L ; Gunduz, Mehmet ; Nagatsuka, Hitoshi ; Gunduz, Esra ; Cengiz, Beyhan ; Fukushima, Kunihiro ; Beder, Levent Bekir ; Demircan, Kadir ; Fujii, Masae ; Yamanaka, Noboru ; Shimizu, Kenji ; Grenman, Reidar ; Nagai, Noriyuki. / Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. In: Cancer Science. 2008 ; Vol. 99, No. 8. pp. 1589-1594.
@article{5f1852298eae44ce9798c7346a0ce5f5,
title = "Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma",
abstract = "The epidermal growth factor receptor (EGFR)-RAS-RAF-mitogen-activated protein kinase signaling cascade is an important pathway in cancer development and recent reports show that EGFR and its downstream signaling molecules are mutated in a number of cancers. We have analyzed 91 Japanese head and neck squamous cell carcinomas (HNSCC) and 12 HNSCC cell lines for mutations in EGFR, ErbB2, and K-ras. Exons encoding the hot-spot regions in the tyrosine kinase domain of both EGFR (exons 18, 19, and 21) and ErbB2 (exons 18-23), as well as exons 1 and 2 of K-ras were amplified by polymerase chain reaction and sequenced directly. EGFR expression was also analyzed in 65 HNSCC patients using immunohistochemistry. Only one silent mutation, C836T, was found in exon 21 of EGFR in the UT-SCC-16A cell line and its corresponding metastasic cell line UT-SCC-16B. No other mutation was found in EGFR, ErbB2, or K-ras. All tumors showed EGFR expression. In 21 (32{\%}) tumors, EGFR was expressed weakly (+1). In 27 (42{\%}) tumors it was expressed (+2) moderately, and in 17 (26{\%}) tumors high expression (+3) was detected. Overexpression (+2, +3) was found in 44 tumors (68{\%}). A worse tumor differentiation and a positive nodal stage were significantly associated with EGFR overexpression (P = 0.02, P = 0.032, respectively). Similar to patients from western ethnicity, mutations are absent or rare in Japanese HNSCC. Protein overexpression rather than mutation might be responsible for activation of the EGFR pathway in HNSCC.",
author = "{Sheikh Ali}, {Mahmoud A L} and Mehmet Gunduz and Hitoshi Nagatsuka and Esra Gunduz and Beyhan Cengiz and Kunihiro Fukushima and Beder, {Levent Bekir} and Kadir Demircan and Masae Fujii and Noboru Yamanaka and Kenji Shimizu and Reidar Grenman and Noriyuki Nagai",
year = "2008",
doi = "10.1111/j.1349-7006.2008.00861.x",
language = "English",
volume = "99",
pages = "1589--1594",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma

AU - Sheikh Ali, Mahmoud A L

AU - Gunduz, Mehmet

AU - Nagatsuka, Hitoshi

AU - Gunduz, Esra

AU - Cengiz, Beyhan

AU - Fukushima, Kunihiro

AU - Beder, Levent Bekir

AU - Demircan, Kadir

AU - Fujii, Masae

AU - Yamanaka, Noboru

AU - Shimizu, Kenji

AU - Grenman, Reidar

AU - Nagai, Noriyuki

PY - 2008

Y1 - 2008

N2 - The epidermal growth factor receptor (EGFR)-RAS-RAF-mitogen-activated protein kinase signaling cascade is an important pathway in cancer development and recent reports show that EGFR and its downstream signaling molecules are mutated in a number of cancers. We have analyzed 91 Japanese head and neck squamous cell carcinomas (HNSCC) and 12 HNSCC cell lines for mutations in EGFR, ErbB2, and K-ras. Exons encoding the hot-spot regions in the tyrosine kinase domain of both EGFR (exons 18, 19, and 21) and ErbB2 (exons 18-23), as well as exons 1 and 2 of K-ras were amplified by polymerase chain reaction and sequenced directly. EGFR expression was also analyzed in 65 HNSCC patients using immunohistochemistry. Only one silent mutation, C836T, was found in exon 21 of EGFR in the UT-SCC-16A cell line and its corresponding metastasic cell line UT-SCC-16B. No other mutation was found in EGFR, ErbB2, or K-ras. All tumors showed EGFR expression. In 21 (32%) tumors, EGFR was expressed weakly (+1). In 27 (42%) tumors it was expressed (+2) moderately, and in 17 (26%) tumors high expression (+3) was detected. Overexpression (+2, +3) was found in 44 tumors (68%). A worse tumor differentiation and a positive nodal stage were significantly associated with EGFR overexpression (P = 0.02, P = 0.032, respectively). Similar to patients from western ethnicity, mutations are absent or rare in Japanese HNSCC. Protein overexpression rather than mutation might be responsible for activation of the EGFR pathway in HNSCC.

AB - The epidermal growth factor receptor (EGFR)-RAS-RAF-mitogen-activated protein kinase signaling cascade is an important pathway in cancer development and recent reports show that EGFR and its downstream signaling molecules are mutated in a number of cancers. We have analyzed 91 Japanese head and neck squamous cell carcinomas (HNSCC) and 12 HNSCC cell lines for mutations in EGFR, ErbB2, and K-ras. Exons encoding the hot-spot regions in the tyrosine kinase domain of both EGFR (exons 18, 19, and 21) and ErbB2 (exons 18-23), as well as exons 1 and 2 of K-ras were amplified by polymerase chain reaction and sequenced directly. EGFR expression was also analyzed in 65 HNSCC patients using immunohistochemistry. Only one silent mutation, C836T, was found in exon 21 of EGFR in the UT-SCC-16A cell line and its corresponding metastasic cell line UT-SCC-16B. No other mutation was found in EGFR, ErbB2, or K-ras. All tumors showed EGFR expression. In 21 (32%) tumors, EGFR was expressed weakly (+1). In 27 (42%) tumors it was expressed (+2) moderately, and in 17 (26%) tumors high expression (+3) was detected. Overexpression (+2, +3) was found in 44 tumors (68%). A worse tumor differentiation and a positive nodal stage were significantly associated with EGFR overexpression (P = 0.02, P = 0.032, respectively). Similar to patients from western ethnicity, mutations are absent or rare in Japanese HNSCC. Protein overexpression rather than mutation might be responsible for activation of the EGFR pathway in HNSCC.

UR - http://www.scopus.com/inward/record.url?scp=49749113623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749113623&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2008.00861.x

DO - 10.1111/j.1349-7006.2008.00861.x

M3 - Article

C2 - 18754871

AN - SCOPUS:49749113623

VL - 99

SP - 1589

EP - 1594

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 8

ER -